210 related articles for article (PubMed ID: 9065060)
1. [Effects of human interferons and 60cobalt radiation on canine and feline tumour cells-preclinical studies].
Kessler M; Hammer AS; Bailey MQ; Tempel KH; Matis U
Zentralbl Veterinarmed A; 1996 Dec; 43(10):599-609. PubMed ID: 9065060
[TBL] [Abstract][Full Text] [Related]
2. Results of radiation treatment of naturally occurring animal tumors.
Banks WC; Morris E
J Am Vet Med Assoc; 1975 Jun; 166(11):1063-4. PubMed ID: 166056
[No Abstract] [Full Text] [Related]
3. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle.
Chang AY; Keng PC
Cancer Res; 1987 Aug; 47(16):4338-41. PubMed ID: 2440565
[TBL] [Abstract][Full Text] [Related]
6. Correlation between initial and long-term responses of spontaneous pet animal tumors to heat and radiation or radiation alone.
Dewhirst MW; Sim DA; Wilson S; DeYoung D; Parsells JL
Cancer Res; 1983 Dec; 43(12 Pt 1):5735-41. PubMed ID: 6640525
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy in small animal medicine: fundamentals, indications and significance].
Kaser-Hotz B; Fodor G; Cordt-Riehle I; Blattmann H; Munkel G; Egger E; LaRue SM; Suter PF
Schweiz Arch Tierheilkd; 1994; 136(10):319-28. PubMed ID: 7801084
[TBL] [Abstract][Full Text] [Related]
8. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
Wilkins RC; Ng CE; Raaphorst GP
Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
[TBL] [Abstract][Full Text] [Related]
10. Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Mitin VN; Kulakov VN; Khokhlov VF; Sheino IN; Arnopolskaya AM; Kozlovskaya NG; Zaitsev KN; Portnov AA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S299-301. PubMed ID: 19428264
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy of ceruminous gland carcinomas in dogs and cats.
Théon AP; Barthez PY; Madewell BR; Griffey SM
J Am Vet Med Assoc; 1994 Aug; 205(4):566-9. PubMed ID: 7961091
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapies in small animals.
Mueller RS; Hartmann K
Vet J; 2021 May; 271():105648. PubMed ID: 33840487
[TBL] [Abstract][Full Text] [Related]
14. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.
Tateyama S; Priosoeryanto BP; Yamaguchi R; Uchida K; Ogiwara K; Suchiya AT
Res Vet Sci; 1995 Nov; 59(3):275-7. PubMed ID: 8588106
[TBL] [Abstract][Full Text] [Related]
15. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
[TBL] [Abstract][Full Text] [Related]
16. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
[TBL] [Abstract][Full Text] [Related]
17. Canine limbal melanoma: 30 cases (1992-2004). Part 2. Treatment with lamellar resection and adjunctive strontium-90beta plesiotherapy--efficacy and morbidity.
Donaldson D; Sansom J; Adams V
Vet Ophthalmol; 2006; 9(3):179-85. PubMed ID: 16634932
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy in veterinary medicine (review)].
von Zallinger C; Tempel K
Berl Munch Tierarztl Wochenschr; 1998 Feb; 111(2):60-9. PubMed ID: 9513299
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
20. Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms.
Moore AS; Theilen GH; Newell AD; Madewell BR; Rudolf AR
Cancer Res; 1991 Jan; 51(1):233-8. PubMed ID: 1899040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
